307 related articles for article (PubMed ID: 31081075)
1. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
Zhao YL; Huang YM
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
[TBL] [Abstract][Full Text] [Related]
2. LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
Li J; Wang AS; Wang S; Wang CY; Xue S; Guan H; Li WY; Ma TT; Shan YX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1022-1029. PubMed ID: 30779068
[TBL] [Abstract][Full Text] [Related]
3. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
4. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
5. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
6. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
Yao N; Yu L; Zhu B; Gan HY; Guo BQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
Wang GF; Wen LN
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
[TBL] [Abstract][Full Text] [Related]
8. SNHG14 promotes the tumorigenesis and metastasis of colorectal cancer through miR-32-5p/SKIL axis.
Ye T; Zhang N; Wu W; Yang B; Wang J; Huang W; Tang D
In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):812-820. PubMed ID: 31471872
[TBL] [Abstract][Full Text] [Related]
9. LAMC2 regulated by microRNA-125a-5p accelerates the progression of ovarian cancer via activating p38 MAPK signalling.
Zhang D; Guo H; Feng W; Qiu H
Life Sci; 2019 Sep; 232():116648. PubMed ID: 31301414
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3.
Sun X; Shen H; Liu S; Gao J; Zhang S
Int J Mol Med; 2020 Jun; 45(6):1685-1696. PubMed ID: 32236565
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p.
Zhao Y; Yuan D; Zhu D; Xu T; Huang A; Jiang L; Liu C; Qian H; Bu X
J Ovarian Res; 2021 Aug; 14(1):109. PubMed ID: 34454554
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LUCAT1 promotes proliferation of ovarian cancer cells by regulating miR-199a-5p expression.
Liu HZ; Liu GY; Pang WW; Zhang H; Zeng ZJ; Wang HJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1682-1687. PubMed ID: 32141534
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-486-5p inhibits ovarian granulosa cell proliferation and participates in the development of PCOS via targeting MST4.
Han XM; Tian PY; Zhang JL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7217-7223. PubMed ID: 31539108
[TBL] [Abstract][Full Text] [Related]
15. CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144.
Sheng M; Wei N; Yang HY; Yan M; Zhao QX; Jing LJ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7283-7294. PubMed ID: 31539115
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA SNHG14 promotes microglia activation by regulating miR-145-5p/PLA2G4A in cerebral infarction.
Qi X; Shao M; Sun H; Shen Y; Meng D; Huo W
Neuroscience; 2017 Apr; 348():98-106. PubMed ID: 28215748
[TBL] [Abstract][Full Text] [Related]
17. The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axis.
Xu Y; Ren Z; Wang X; Ren M
J Gene Med; 2022 May; 24(5):e3413. PubMed ID: 35106863
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
19. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
